- Home
- Publications
- Publication Search
- Publication Details
Title
CD30: from basic research to cancer therapy
Authors
Keywords
Memory, CCR7, Asthma, Colitis, Mucosal immunity, Th17, Hodgkin, ALCL
Journal
IMMUNOLOGIC RESEARCH
Volume 57, Issue 1-3, Pages 151-158
Publisher
Springer Nature
Online
2013-11-13
DOI
10.1007/s12026-013-8464-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Critical Synergy of CD30 and OX40 Signals in CD4 T Cell Homeostasis and Th1 Immunity to Salmonella
- (2014) F. Gaspal et al. JOURNAL OF IMMUNOLOGY
- A Novel Role of CD30L/CD30 Signaling by T-T Cell Interaction in Th1 Response against Mycobacterial Infection
- (2014) C. Tang et al. JOURNAL OF IMMUNOLOGY
- CD30 Is Required for Activation of a Unique Subset of Interleukin-17A-Producing γδ T Cells in Innate Immunity against Mycobacterium bovis Bacillus Calmette-Guérin Infection
- (2013) Ying Guo et al. INFECTION AND IMMUNITY
- CD30L/CD30 is critical for maintenance of IL-17A-producing γδ T cells bearing Vγ6 in mucosa-associated tissues in mice
- (2013) X Sun et al. Mucosal Immunology
- Molecular profiling of tumor-specific TH1 cells activated in vivo
- (2013) Kristina Berg Lorvik et al. OncoImmunology
- CD30 Ligand/CD30 Interaction Is Involved in Pathogenesis of Inflammatory Bowel Disease
- (2012) Shinichi Somada et al. DIGESTIVE DISEASES AND SCIENCES
- The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice
- (2011) Takafumi Fuchiwaki et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice
- (2011) Fabrina M.Gaspal et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD30: an important new target in hematologic malignancies
- (2011) Yehuda E. Deutsch et al. LEUKEMIA & LYMPHOMA
- Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate
- (2010) N. M. Okeley et al. CLINICAL CANCER RESEARCH
- CD30 Ligand/CD30 Plays a Critical Role in Th17 Differentiation in Mice
- (2010) X. Sun et al. JOURNAL OF IMMUNOLOGY
- CD30 Ligand Is a Target for a Novel Biological Therapy against Colitis Associated with Th17 Responses
- (2010) X. Sun et al. JOURNAL OF IMMUNOLOGY
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma
- (2009) Andres Forero-Torres et al. BRITISH JOURNAL OF HAEMATOLOGY
- Susceptibility of human T-cell leukemia virus type I-infected cells to humanized anti-CD30 monoclonal antibodies in vitro and in vivo
- (2009) Naoyoshi Maeda et al. CANCER SCIENCE
- The Role of Costimulatory Molecules in Allergic Disease and Asthma
- (2009) Vincent Lombardi et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- CD30 Is Required for CCL21 Expression and CD4 T Cell Recruitment in the Absence of Lymphotoxin Signals
- (2009) V. Bekiaris et al. JOURNAL OF IMMUNOLOGY
- Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells
- (2009) Marion Pepper et al. NATURE IMMUNOLOGY
- A Critical Role of CD30 Ligand/CD30 in Controlling Inflammatory Bowel Diseases in Mice
- (2008) Xun Sun et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started